2011 Annual Report Australasian Kidney Trials Network University of Queensland www.aktn.org.au

First Page		Document Content
Date: 2012-07-03 00:47:16 Membrane technology Clinical research Pharmaceutical industry Home hemodialysis Clinical trial Chronic kidney disease Dialysis Hemodialysis Robert Provenzano Medicine Nephrology Renal dialysis		2011 Annual Report Australasian Kidney Trials Network University of Queensland www.aktn.org.au Add to Reading List Source URL: www.aktn.org.au Download Document from Source Website File Size: 2,08 MB Share Document on Facebook

	Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town DocID: 1vj68 - View Document
	Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro DocID: 1uEgV - View Document
	conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics September 29-30, 2016 Orlando, USA DocID: 1uvE8 - View Document
	Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro DocID: 1uvxq - View Document
	NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results DocID: 1tmLJ - View Document